ddI--a good start, but still phase I

Editorial

A S Fauci. N Engl J Med. 1990.

. 1990 May 10;322(19):1386-8.

doi: 10.1056/NEJM199005103221909.

No abstract available

Comment on

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial.
Lambert JS, Seidlin M, Reichman RC, Plank CS, Laverty M, Morse GD, Knupp C, McLaren C, Pettinelli C, Valentine FT, et al. Lambert JS, et al. N Engl J Med. 1990 May 10;322(19):1333-40. doi: 10.1056/NEJM199005103221901. N Engl J Med. 1990. PMID: 2139173
Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.
Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, McCaffrey RP, Liebman HA. Cooley TP, et al. N Engl J Med. 1990 May 10;322(19):1340-5. doi: 10.1056/NEJM199005103221902. N Engl J Med. 1990. PMID: 2139174